injection-site reaction rate was not dose-dependent in the data published
Hexarelin is another example, and it was involved in some cardiac disease research, and it has some potential in cardiovascular recovery after major events, but for now as many other peptides, the data comes from observational studies and animal studies rather than radomized controlled trials, and care should always be taken when using them, and always be supervised by a knowledgeable medical provider
human dosing guidelines and administration schedules Journal of Neurology and Psychiatry (Russia) Clinical trial of Semax in ischemic stroke patients (6,000 mcg/day intranasal protocol with cycling) Peptides.org Semax dosage overview, cycling recommendations, and protocol duration guidance Journal of Higher Nervous Activity (Russia) Early human study introducing Semax's nootropic properties and mechanism of action Vestnik Oftalmologii (Russian Ophthalmology Journal) Human study of Semax in glaucomatous optic neuropathy
Here are the most notable findings from a study involving mice with growth hormone deficiencya condition that leads to stunted growth, reduced lean mass, and increased abdominal fat [17]: Enhanced growth and lean body mass: Growth hormone deficient (GHD) mice exhibited approximately 20% less lean body mass than normal, struggling to attain regular body size or weight